Axogen, Inc. Operating Lease, Payments
Axogen, Inc. (AXGN) reported Operating Lease, Payments of $463.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2022-02-25
- Axogen, Inc. operating lease, payments for the quarter ending 2021-03-31 was -$119.00K, a 125.21% decline year-over-year.
- Axogen, Inc. operating lease, payments for the quarter ending 2020-12-31 was -$127.00K, a 125.55% decline year-over-year.
- Axogen, Inc. operating lease, payments for the quarter ending 2020-09-30 was $298.00K, a 30.70% decline year-over-year.
- Axogen, Inc. operating lease, payments for the quarter ending 2020-06-30 was $443.00K, a 4.73% increase year-over-year.
- Axogen, Inc. operating lease, payments for fiscal 2021 was $463.00K, a 57.37% decline from fiscal 2020.
- Axogen, Inc. operating lease, payments for fiscal 2020 was $1.09M, a 38.75% decline from fiscal 2019.
- Axogen, Inc. operating lease, payments for fiscal 2019 was $1.77M.
- Axogen, Inc. operating lease, payments for fiscal 2018 was $0.00.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2021-12-31 | $463.00K 10-K · filed 2022-02-25 | |||
| 2021-03-31 | -$119.00K 10-Q · filed 2021-05-06 | -$246.00K derived: sum of 2 quarters · filed 2022-02-25 | $52.00K derived: sum of 3 quarters · filed 2022-02-25 | $495.00K derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-12-31 | -$127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $171.00K derived: sum of 2 quarters · filed 2022-02-25 | $614.00K derived: sum of 3 quarters · filed 2022-02-25 | $1.09M 10-K · filed 2022-02-25 |
| 2020-09-30 | $298.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $741.00K derived: sum of 2 quarters · filed 2020-10-30 | $1.21M 10-Q · filed 2020-10-30 | $1.71M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $443.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $915.00K 10-Q · filed 2020-08-07 | $1.41M derived: sum of 3 quarters · filed 2022-02-25 | $1.84M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $472.00K 10-Q · filed 2021-05-06 | $969.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.40M derived: sum of 3 quarters · filed 2022-02-25 | $1.82M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $497.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $927.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.35M derived: sum of 3 quarters · filed 2022-02-25 | $1.77M 10-K · filed 2022-02-25 |
| 2019-09-30 | $430.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $853.00K derived: sum of 2 quarters · filed 2020-10-30 | $1.28M 10-Q · filed 2020-10-30 | |
| 2019-06-30 | $423.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $846.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $423.00K 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |